Potential hazards in the analysis of symptom improvement

Recommendations for the use of clinical outcome assessments in rare disease drug development.

EClinicalMedicine·2026

The anti-CD33 antibody drug conjugate gemtuzumab ozogamicin depletes and functionally resets CD33+ myeloid-derived suppressor cells in patients with metastatic cancer: a phase 2 single-arm, open-label trial.

Journal of leukocyte biology·2026

Foundry-enabled wafer-scale characterization and modeling of silicon photonic DWDM links.

Nanophotonics (Berlin, Germany)·2025

Final results of ANICCA-Class II, a single arm, open-label phase II trial assessing nivolumab in tissue-specific class II expressing metastatic microsatellite stable colorectal cancer, with a parallel assessment of the immunoscore-immune checkpoint as a predictive biomarker for single-agent anti-PD-1.

Journal for immunotherapy of cancer·2025

SARS-CoV-2-Specific Immune Responses to Vaccination in Children and Adolescents with Suppressed Immune Systems: A Prospective, Observational Study.

The Journal of pediatrics·2025

Selumetinib in Combination with Anti Retroviral Therapy in HIV-associated Kaposi sarcoma (SCART): an open-label, multicentre, phase I/II trial.

BMC cancer·2025

Genomic Profiling, Risk Stratification, and Post-Transformation Treatment Outcomes in Patients with Transformed Small-Cell Lung Cancer: A Multicenter Analysis.

Lung cancer (Amsterdam, Netherlands)·2026

Efficacy and prognostic analysis of induction chemoimmunotherapy in unresectable stage Ⅲ non-small cell lung cancer: a single-center retrospective study.

Lung cancer (Amsterdam, Netherlands)·2026

Biology, detection, and management of incidental pulmonary nodules: the emerging role of targeted treatments. A review of the current literature and future perspectives.

Lung cancer (Amsterdam, Netherlands)·2026

Distinct spatial immune microenvironment features of different EGFR mutation subtypes in early-stage lung adenocarcinoma.

Lung cancer (Amsterdam, Netherlands)·2026

A phase 2 study of encorafenib in combination with binimetinib for Chinese participants with BRAFV600E mutated metastatic non-small cell lung cancer: Results from the OCEAN II study.

Lung cancer (Amsterdam, Netherlands)·2026

Treatment-stratified associations of pathological complete response with survival in resected limited-stage small cell lung cancer: A multicenter retrospective study with exploratory spatial immune profiling.

Lung cancer (Amsterdam, Netherlands)·2026

Aerosol pH Associated with Preterm Birth Risk: Unmasking the Hidden Role of Atmospheric Acidity in Maternal-Fetal Health.

Environmental pollution (Barking, Essex : 1987)·2026

Photochemical ultrafine particles pose potential inflammatory risk despite low PM2.5 mass.

Environment international·2026

Cognitive risk during underwater exposure: from environmental stressors to assessment and context-aware monitoring.

Frontiers in physiology·2026

Association between meteorological factors and blood pressure variability in northern Guizhou, China.

Frontiers in public health·2026

Determinants of serum aflatoxin B1 exposure among pregnant women in coastal Kenya: a cross-sectional study in Kwale County.

Tropical medicine and health·2026

PFAS at a closed fluorochemical manufacturing facility in China: multi-media contamination and human health risks.

Environmental pollution (Barking, Essex : 1987)·2026

Related Experiment Videos

Potential hazards in the analysis of symptom improvement

Related Concept Videos

Recommendations for the use of clinical outcome assessments in rare disease drug development.

The anti-CD33 antibody drug conjugate gemtuzumab ozogamicin depletes and functionally resets CD33+ myeloid-derived suppressor cells in patients with metastatic cancer: a phase 2 single-arm, open-label trial.

Foundry-enabled wafer-scale characterization and modeling of silicon photonic DWDM links.

SARS-CoV-2-Specific Immune Responses to Vaccination in Children and Adolescents with Suppressed Immune Systems: A Prospective, Observational Study.

Selumetinib in Combination with Anti Retroviral Therapy in HIV-associated Kaposi sarcoma (SCART): an open-label, multicentre, phase I/II trial.

Genomic Profiling, Risk Stratification, and Post-Transformation Treatment Outcomes in Patients with Transformed Small-Cell Lung Cancer: A Multicenter Analysis.

Efficacy and prognostic analysis of induction chemoimmunotherapy in unresectable stage Ⅲ non-small cell lung cancer: a single-center retrospective study.

Biology, detection, and management of incidental pulmonary nodules: the emerging role of targeted treatments. A review of the current literature and future perspectives.

Distinct spatial immune microenvironment features of different EGFR mutation subtypes in early-stage lung adenocarcinoma.

A phase 2 study of encorafenib in combination with binimetinib for Chinese participants with BRAFV600E mutated metastatic non-small cell lung cancer: Results from the OCEAN II study.

Treatment-stratified associations of pathological complete response with survival in resected limited-stage small cell lung cancer: A multicenter retrospective study with exploratory spatial immune profiling.

Aerosol pH Associated with Preterm Birth Risk: Unmasking the Hidden Role of Atmospheric Acidity in Maternal-Fetal Health.

Photochemical ultrafine particles pose potential inflammatory risk despite low PM2.5 mass.

Cognitive risk during underwater exposure: from environmental stressors to assessment and context-aware monitoring.

Association between meteorological factors and blood pressure variability in northern Guizhou, China.

Determinants of serum aflatoxin B1 exposure among pregnant women in coastal Kenya: a cross-sectional study in Kwale County.

PFAS at a closed fluorochemical manufacturing facility in China: multi-media contamination and human health risks.

Related Experiment Videos

Potential hazards in the analysis of symptom improvement

Related Concept Videos

Related Articles